Read More Pharma Industry News Evaxion’s AI-designed cancer vaccine gains momentum as new melanoma data put EVAX stock in focus Evaxion's EVX-01 melanoma vaccine nears new Phase 2 data as EVAX stock faces pressure. Discover its AI strategy, partnerships and outlook. bySoujanya RaviNovember 6, 2026